Cell therapy weekly: First CAR-T cell clinical trial for cancer kickstarted in New Zealand
This week: A manufacturing collaboration seeks to optimize the cell and gene therapy product supply chain, a novel viral vector improves sickle cell gene therapy delivery and a new cGMP manufacturing facility for iPSC-derived therapies.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>